Graves’ disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Cohen, J. A., Coles, A. J., Arnold, D. L., Confavreux, C., Fox, E. J., Hartung, H.-P., Havrdova, E., Selmaj, K. W., Weiner, H. L., Fisher, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61769-3 · Cited by 1,205 · see citing works

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098 · see citing works

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A., Hale, G., Chatterjee, V. K., Waldmann, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02429-0 · Cited by 453 · see citing works

Interferon-α and Autoimmune Thyroid Disease

Prummel, M. F., & Laurberg, P. (2003) · Thyroid · doi:10.1089/105072503322238809 · Cited by 221 · see citing works

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort

Cossburn, M., Pace, A. A., Jones, J., Ali, R., Ingram, G., Baker, K., Hirst, C., Zajicek, J., Scolding, N., Boggild, M., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228bec5 · Cited by 216 · see citing works

Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H)

Walsh, M., Chaudhry, A., & Jayne, D. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.081661 · Cited by 178 · see citing works

Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis

Daniels, G. H., Vladic, A., Brinar, V., Zavalishin, I., Valente, W., Oyuela, P., Palmer, J., & Margolin, D. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2201 · Cited by 150 · see citing works

Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease

Chen, F., Day, S. L., Metcalfe, R. A., Sethi, G., Kapembwa, M. S., Brook, M. G., Churchill, D., de Ruiter, A., Robinson, S., Lacey, C. J., et al. (2005) · Medicine · doi:10.1097/01.md.0000159082.45703.90 · Cited by 142 · see citing works

Sequential Occurrence of Thyroid Autoantibodies and Graves' Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected Patients

Jubault, V., Penfornis, A., Schillo, F., Hoen, B., Izembart, M., Timsit, J., Kazatchkine, M. D., Gilquin, J., & Viard, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6988 · Cited by 135 · see citing works

Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs

Torino, F., Barnabei, A., Paragliola, R., Baldelli, R., Appetecchia, M., & Corsello, S. M. (2013) · Thyroid® · doi:10.1089/thy.2013.0241 · Cited by 117 · see citing works

Thyrotoxicosis induced by alpha‐interferon therapy in chronic viral hepatitis

Wong, V., Fu, A. X., George, J., & Cheung, N. W. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01553.x · Cited by 106 · see citing works

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

Cuker, A. C., Coles, A. J., Sullivan, H., Fox, E., Goldberg, M. A., Oyuela, P., Purvis, A., Beardsley, D. S., & Margolin, D. H. (2011) · Blood · doi:10.1182/blood-2011-08-371138 · Cited by 105 · see citing works

Immune reconstitution syndrome and the thyroid

Weetman, A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.003 · Cited by 87 · see citing works

Autoimmune Thyroid Disease After Renal Transplantation Using Depletional Induction with Alemtuzumab

Kirk, A. D., Hale, D. A., Swanson, S. J., & Mannon, R. B. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01258.x · Cited by 71 · see citing works

No association between HIV disease and its treatment and thyroid function

Madge, S., Smith, C. J., Lampe, F. C., Thomas, M., Johnson, M., Youle, M. S., & Vanderpump, M. P. J. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00422.x · Cited by 50 · see citing works

Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells

Karthaus, M., Gabrysiak, T., Brabant, G. E., Prahst, A., Link, H., Soudah, B., Geißler, R. G., Diedrich, H., Ganser, A., & Hertenstein, B. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700955 · Cited by 40 · see citing works

Autoimmune Diabetes in HIV-Infected Patients on Highly Active Antiretroviral Therapy

Takarabe, D., Rokukawa, Y., Takahashi, Y., Goto, A., Takaichi, M., Okamoto, M., Tsujimoto, T., Noto, H., Kishimoto, M., Kaburagi, Y., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0055 · Cited by 40 · see citing works

Use of Color Doppler Ultrasonography to Measure Thyroid Blood Flow and Differentiate Graves' Disease from Painless Thyroiditis

Hiraiwa, T., Tsujimoto, N., Tanimoto, K., et al. (2013) · European Thyroid Journal · doi:10.1159/000350560 · Cited by 33 · see citing works

Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy

Yang, J.-J., Tsai, M., Sun, H., Hsieh, S., Chen, M.-Y., Sheng, W., & Chang, S. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.08.002 · Cited by 31 · see citing works

Graves' Disease after Interleukin-2 Therapy in a Patient with Human Immunodeficiency Virus Infection

Jiménez, C., Moran, S. A., Sereti, I., Wynne, S., Yen, P. M., Falloon, J., Davey, R. T., & Sarlis, N. J. (2004) · Thyroid · doi:10.1089/thy.2004.14.1097 · Cited by 29 · see citing works

Hashimoto's Thyroiditis Presenting as Acute Painful Thyroiditis and as a Manifestation of an Immune Reconstitution Inflammatory Syndrome in a Human Immunodeficiency Virus–Seropositive Patient

Visser, R., de Mast, Q., Netea-Maier, R. T., & van der Ven, A. J. A. M. (2012) · Thyroid · doi:10.1089/thy.2012.0055 · Cited by 29 · see citing works

Graves’ disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4+ T-cell recovery

Sheikh, V., DerSimonian, R., Richterman, A. G., Porter, B. O., Natarajan, V., Burbelo, P. D., Rupert, A. W., Santich, B. H., Kardava, L., Mican, J. M., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000006 · Cited by 29 · see citing works

Graves' Immune Reconstitution Inflammatory Syndrome in Childhood

Sinha, A., Abinun, M., Gennery, A. R., Barge, D., Slatter, M. A., & Cheetham, T. D. (2013) · Thyroid · doi:10.1089/thy.2012.0618 · Cited by 18 · see citing works

Appearance of Thyroid Stimulating and Blocking Immunoglobulins after Bone Marrow Transplantation: Presentation of Two Contrasting Cases

Yamamori, I., Kanie, T., Maeda, N., Kodera, Y., Matsuyama, T., & Hasegawa, H. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.439 · Cited by 17 · see citing works

Patterns of Interferon-Alpha–Induced Thyroid Dysfunction Vary with Ethnicity, Sex, Smoking Status, and Pretreatment Thyrotropin in an International Cohort of Patients Treated for Hepatitis C

Mammen, J. S., Ghazarian, S. R., Rosen, A., & Ladenson, P. W. (2013) · Thyroid · doi:10.1089/thy.2012.0565 · Cited by 13 · see citing works

Type B Insulin Resistance Syndrome Associated with an Immune Reconstitution Inflammatory Syndrome in an HIV-Infected Woman

Mohammedi, K., Roussel, R., Dbouni, O. E., Potier, L., Khalil, C. A., Capel, É., Vigouroux, C., Caron, M., Capeau, J., & Marre, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1949 · Cited by 13 · see citing works

Graves Disease after Bone Marrow Transplantation

Takeshita, A., Shinjo, K., & Ohno, R. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-2-199907200-00023 · Cited by 11 · see citing works

Reconstitution Graves' disease following autologous haematopoietic stem cell transplantation for severe diffuse systemic sclerosis

Tailor, I. K., Akil, M., Rennie, I. G., Ross, R. J. M., & Snowden, J. A. (2011) · QJM · doi:10.1093/qjmed/hcr050 · Cited by 9 · see citing works

Short Communication: CD4 Cell Count Increases During Successful Treatment of Graves' Disease with Methimazole in HIV-Infected Patients on Antiretroviral Therapy

Honda, A., Kashiwazaki, K., Tsunoda, T., Gallant, J. E., & Brown, T. T. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0309 · Cited by 6 · see citing works

Graves' orbitopathy in a patient with adrenoleukodystrophy after bone marrow transplantation

Vardizer, Y., Lupetti, A., Vandelanotte, S., Lankester, A. C., Wiersinga, W. M., & Baldeschi, L. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0944 · Cited by 4 · see citing works

Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features

Pariani, N., Willis, M., Muller, I., Healy, S., Nasser, T., McGowan, A., Lyons, G., Jones, J., Chatterjee, K., Dayan, C., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00359 · Cited by 84 · see citing works

2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy

Muller, I., Moran, C., Lecumberri, B., Decallonne, B., Robertson, N., Jones, J., & Dayan, C. M. (2019) · European Thyroid Journal · doi:10.1159/000500881 · Cited by 78 · see citing works

Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy

Edmunds, M. R., Mellington, F., Ford, R. L., Torlinska, B., Manavi, K., & Boelaert, K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3544 · Cited by 14 · see citing works

A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.

Charlton, A., Spence, L. E., Bigley, V., et al. (2009) · Blood · doi:10.1182/blood.v114.22.3333.3333

Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients

for The Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia, I. C. W. T. C. L. S. G. F. L., Fiegl, M., Falkner, F., Steurer, M., Zojer, N., Hopfinger, G., Haslbauer, F., Winder, G., Voskova, D., Andel, J., et al. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1192-5 · Cited by 8 · see citing works

Emerging role of Alemtuzumab in renal and renal–pancreas transplantation

Sureshkumar, K. K., Hussain, S. M., Zimmer, B. W., et al. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.10.1605 · Cited by 6 · see citing works

Updated Guidelines on the Management of Cytomegalovirus Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Alemtuzumab

O'Brien, S. M., Keating, M. J., & Mocarski, E. S. (2006) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2006.n.049 · Cited by 93 · see citing works

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML

Malladi, R. K., Peniket, A., Littlewood, T. J., Towlson, K. E., Pearce, R., Yin, J. A. L., Cavenagh, J. D., Craddock, C., Orchard, K. H., Olavarría, E., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.375 · Cited by 35 · see citing works